Kristine E. Burgess
Assistant Professor
Department of Clinical Sciences
Oncology
Phone: 508-839-5395 x84251
Fax: 508-839-7922 or 7951
Email: kristine.burgess@tufts.edu
Education
DVM - Tufts University 1997
MS - Harvard University 1991
BS - University of Massachusetts 1988
Board Certification
American College of Veterinary Internal Medicine - Oncology
General Research and Clinical Interest
- Understanding the molecular mechanisms that trigger the development of canine / feline cancer and applying those findings into improved diagnostic capabilities and therapeutic options for treatment
- Participating in clinical trials that evaluate the use of novel chemotherapeutics and immunotherapies in various malignancies
Research Sponsor Interest
- Privately Funded Research
- Federally Funded Research
Selected Publications
- Rau SE and Burgess KE (2008) PRL-3 Expression in Metastatic Cancers Veterinary Cancer Society Newsletter
- Risbon R, de Lorimier LP, Skorupski K, Burgess KE, et al. (2006) Response of Canine Cutaneous Epitheliotropic Lymphoma to Lomustine (CCNU): A Retrospective Study of 46 Cases (1999–2004) Journal of Veterinary Internal Medicine20(6) 1389-1397.
- Poirier VJ, Hershey AE, Burgess KE, Phillips B, Turek MT, Forrest LJ, Beaver L, and Vail DM, (2004) Efficacy and toxicity of Paclitaxel (Taxol) for the treatment of canine malignant tumors Journal of Veterinary Internal Medicine 18 (2): 219-222.
- Poirier VJ, Burgess KE, Adams WM, Vail DM (2004) Toxicity, dosage and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. Journal of Veterinary Internal Medicine 18(4) 536-539.